Listen "Erin Duffy and the Roller Coaster of Antibiotic Development"
Episode Synopsis
In this episode of Superbugs Unplugged, our guest, Dr. Erin Duffy, discusses the global health threat of antimicrobial resistance (AMR), and why and how her non-profit, CARB-X, is investing in diverse products to help overcome common challenges faced in Low- and Middle-Income Countries (LMICs). Dr. Duffy is the Chief of R&D at CARB-X, a global biopharmaceutical accelerator for the discovery and early development of products to prevent, diagnose and treat resistant bacterialinfections. Prior to CARB-X, Dr. Duffy served as Chief Scientific Officer of Melinta Therapeutics.
More episodes of the podcast Superbugs Unplugged
We Talk A Lot About Poop
29/09/2023
Water, Sanitation, Hygiene & Superbugs
20/07/2023
Goodbye Co-Host Matt, You Will Be Missed
15/05/2023
To PASTEUR or not to PASTEUR
26/01/2023
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.